U.S. markets close in 5 hours 38 minutes

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
340.57-0.25 (-0.07%)
As of 10:22AM EST. Market open.
Sign in to post a message.
  • H
    Ham
    yes, Simon Barnett thinks Grail will require a lot of funding, probably a capital raise and in any event bis inferior technology compared to alternative liquid biopsy tests under trial from competitors.
    Neutral
  • H
    Ham
    deal with the NHS today, pre commercial rollout of Galleri
    Bullish
  • N
    Nathan
    ark sold completely out of illumnia
  • K
    Kevin
    Let's keep political hate off board. We have a 2 party system, give and take. It's our system.
  • H
    Ham
    the call seems fairly positive to me. and Francis's explanation of why the price for Grail was much higher than that which exact paid for thrive made sense (commercial launch next year, existing FDA approval for Galleri test results going back to patients on the trials). sure it will be earnings dilutive for a while but having the first to market multi cancer liquid biopsy test is a major advantage and will open up a massive market for instruments and consumables for Illumina. and they seemed pretty bullish on returning growth to instruments and. consumables over q2 saying it was a new baseline for future expansion not just catch up. the other interactive point was Francis saying that during the pandemic blood testing has been a consistent metric even though tissue declined and that he expects this to be a permanent change, again positive for Grail.
    Bullish
  • D
    D$
    @ham I’m curious to get your perspective on the revenue impact Covid 19 will have on Illumina’s earnings with respect to partnerships like Helix, based in San Diego, who are ramping up testing to 100,000 per day on the Novaseq platform. How material of a positive impact do you see Covid testing and the sequencing research being performed on the virus affecting earnings?
    https://www.fda.gov/media/140917/download
  • A
    Albertus
    Stunning move by ARK.
  • G
    Greg
    Bought PACB, when ILMN tried to buy it, but now I'm thinking of selling ILMN and buying more PACB. Thoughts?
    Bullish
  • J
    Jimmy
    ILMN beat earnings estimates, anyone knows why post-market is red?
  • D
    D$
    It seems like the whole genomics space has had a meteoric rise recently, Exact, NVTA, GH, Crispr, etc without correlation to revenue. I’m a little surprised to see ILMN’s share price below their pre-acquisition level. 🤞for a strong Q3 earnings report
  • H
    Ham
    not many watching this stock now. Ark have lost faith and sold half their holdings. they're backing Invitae as a winner in genetics, buy I'm not convinced that their strategy of buying as many tests as possible and hoping it makes genetics more widely available and adopted is the right one. who knows when they will be profitable. Illumina is the undisputed market leader in genomic sequencing and Grail puts it firmly back into growth mode, assuming the liquid biopsy test is successful, which I'm sure they must have been very sure of before agreeing this deal. then with sales rebounding this third quarter, the quality of the high earnings must stand out. shares are climbing back up to pre Grail deal levels, but I wish I'd bought after the announcement rather than before. still, I can't time the markets except with hindsight so I will hold for the long term. we should see $400 before too long, hopefully after an upbeat earnings call.
    Bullish
  • W
    William
    I am relatively new to being invested in Illumina. I have been invested in NanoString [NSTG] since 2014. So i understand some of the basic concepts in this sector. I am listening to the conference call; and i would appreciate any ~ but i would appreciate any balanced commentary you long-time ILMN investors can provide. Thanks in advance & good luck to all of us longs.
    Bullish
  • D
    Dragan
    Congratulation America. You will tear down "that wall", open borders for all ( including illegals, and your enemies ), get more taxes and spend more money on endless wars, tear down own economy, send you companies and intellectual properties to "friendly" China, work with globalists on universal religion ( if any ), healthcare and monthly salaries for everyone, lock down and lock in everyone who wants freedom. Congratulations America, you did it with "deep state", Soros, "progressive" media and tech giants. What is next? Forced vaccination for everyone and mandatory chips for all?
  • H
    Ham
    Ark K have now sold all their holdings, well 9,000 left end of yesterday. They're backing ExacS instead. I still think FdS must know that Galleri is a shoe in, and he's also a proven entrepreneur. if he's got it right, in hindsight the acquisition will have been cheap. If Ark have got it right, then we will lose out significantly as shareholders. But even Cathie Wood can't be right all the time!
    Bullish
  • W
    William
    Anyone shorts commenting on the current post-market price action have not a notion of what they post. But of course most of us know that here.
    Bullish
  • B
    B
    Such LOW VOLUME DECLINE means weak hands are leaving!!!
    Bullish
  • W
    Wilber
    Illumina, Inc. reportedly, making a push into the cancer diagnostics space. According to an article published Wednesday by Reuters citing "people familiar with the matter," On the other hand, Bullish are aggressive on this new trend, you might want to check this one: http://psce.pw/LowFloatNasdaqStocksMustSeePicks
    Top Nasdaq Low Float Stocks, Super Nova Potential!
    Top Nasdaq Low Float Stocks, Super Nova Potential!
    psce.pw
    Bullish
  • K
    Kaide
    My put from Monday is still gaining here's my cheers to $250
    Bearish
  • P
    Parwinder
    350 + tomorrow exas related
  • D
    Dragan
    It is simple, Biden win ILMN go to 250, Trump win ILMN go to 350.....